[Autoimmune acquired coagulation factor XIII/13 deficiency caused by type Ab anti-FXIII-A autoantibody]

Rinsho Ketsueki. 2023;64(12):1508-1513. doi: 10.11406/rinketsu.64.1508.
[Article in Japanese]

Abstract

An 88-year-old man became unconscious and was admitted to our hospital due to severe anemia. Extensive subcutaneous hemorrhage around the chest and back and pectoralis major muscle hematoma were observed. Coagulation screening tests showed moderately reduced factor XIII/13 (FXIII) activity. During hospitalization, the patient had repeated bleeding events in the gastrointestinal tract and muscles, leading to hemorrhagic shock. We suspected the presence of FXIII inhibitors from FXIII infusion test results. The cross-mixing test for cross-linking of fibrin revealed inhibition of polymerization of α-chain and α2-plasmin inhibitor incorporation into fibrin. In addition, by detecting IgG autoantibody to thrombin-activated FXIII, we confirmed the presence of type Ab anti-FXIII-A subunit autoantibody, which represses the catalytic subunit activity of activated FXIII. Autoimmune FXIII deficiency should be considered when a patient presents with severe hemorrhagic diathesis with no other cause than moderately reduced of FXIII activity, as reported in this case.

Keywords: Acquired bleeding disorder; Acquired coagulation factor deficiency; Autoantibody; Factor XIII.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged, 80 and over
  • Autoantibodies
  • Factor XIII
  • Factor XIII Deficiency* / complications
  • Factor XIII Deficiency* / diagnosis
  • Fibrin
  • Hemorrhage
  • Hemorrhagic Disorders*
  • Humans
  • Male

Substances

  • Factor XIII
  • Autoantibodies
  • Fibrin